Cipher Pharmaceuticals (TSX:CPH) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSX:CPH Cipher Pharmaceuticals Inc TSX:CPH
100 GF Score
Price C$16.39
GF Value C$17.16
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Cipher Pharmaceuticals FFO per Share?

FFO per Share only applies to REITs.

TSX:CPH
100GF Score
Cipher Pharmaceuticals Inc TSX:CPH
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Cipher Pharmaceuticals (TSX:CPH) Overvalued in 2026?

Based on GuruFocus' analysis, Cipher Pharmaceuticals stock appears to be undervalued. The current stock price of C$16.39 is trading 4.5% below its estimated GF Value™ of C$17.16. GuruFocus considers Cipher Pharmaceuticals to be Fairly Valued.

Key valuation signals for TSX:CPH:

  • FFO per Share:
  • GF Value™: C$17.16 vs. price of C$16.39 (4.5% below fair value)
  • GF Score™: 100/100 with 5 warning signs

No single metric tells the full story. See the TSX:CPH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cipher Pharmaceuticals Business Description

Other Exchanges CPHRF:USAPHE:Germany
Address 5750 Explorer Drive, Suite 404, Mississauga, ON, CAN, L4W 0A9
Cipher Pharmaceuticals Inc is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products. The Company is building its business through product acquisitions, out-licensing, and in-licensing arrangements. Its products include Dermatology Products, Hospital Acute Care Products, specialty medicines, and Out-Licensed Products, among others. The company's geographical operational areas include Canada and the United States.
100GF Score

Get the complete analysis for TSX:CPH

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$16.39
Price
C$17.16
GF Value